DIL approves Scheme of Amalgamation with subsidiary FBL
Amalgamation to be value accretive to shareholders in addition to other benefits
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sebi to act against pharma cos in case of non-disclosure of material information
Ajay Tyagi, Chairman, SEBI, was replying to questions pertaining to pharma companies
Strides Shasun gets WHO pre-qualification for rectal artesunate product
Collaborates with Medicines for Malaria Venture and receives funding from Unitaid
India for formal recognition of traditional medicines in Singapore
Documents related to Ayurvedic and Siddha medicines have been submitted to the Singapore Health Authority
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
Doctors will analyse the trial results closely to assess whether GSK can indeed rewrite treatment standards by delivering a…
Cipla receives final approval for testosterone injection
Cypionate Injection is AO-rated generic therapeutic equivalent version of Pharmacia and Upjohn’s DepoTestosterone
Roche buys Foundation Medicine for $2.4 billion
The drugmaker first bought a 56 per cent stake in FMI for $1 billion in 2015
FDD Leaders Handbook
The Leaders featured in this Handbook are the minds and hands that have shaped and are shaping FDD research in India as well as…
The export potential of Russian pharma products is growing
Recently, the Chamber of Commerce and Industry of the Republic of Tatarstan signed an MoU with the Council for Economic…
Pharma industry posts 35 deals worth $5 bn in May 2018
Domestic players played more active role in deal making as compared to crossborder companies